mSafety for clinical and pharmaceutical trials and studies
Accelerate your clinical trials with the mSafety remote monitoring platform
Accelerate your clinical trials with the mSafety remote monitoring platform
Accelerate your clinical trials with the mSafety remote monitoring platform
Poor compliance in clinical trials has long been an issue for pharmaceuticals researchers. Now, thanks to mSafety’s continuous data flow and bi-directional communication capabilities, you can stay in touch with participants throughout your trials and respond to compliance issues in good time. Easily remind people to take their medication via the mSafety device and get confirmation when they have.
Using the mSafety platform to conduct trials remotely reduces the amount of time and money spent on meeting participants face-to-face and collecting data manually. More time and funds therefore become available for additional research and further trials.
Using the mSafety platform to conduct trials remotely reduces the amount of time and money spent on meeting participants face-to-face and collecting data manually. More time and funds therefore become available for additional research and further trials.
Create applications that suit the needs of your specific trial. With built-in sensors and potential to connect to external sensors the mSafety wearable provides an excellent basis to build on. Devices are shipped with your application pre-loaded.
With mSafety, trial results no longer depend on the participants’ own recollection of events, since insights into their health status and behaviour are uploaded with whatever frequency you decide on. You can easily manage and update your fleet of devices via Sony's mSafety portal.
Thanks to a global roaming profile and data subscription plan, patient data is uploaded automatically, with a seamless connection between in- and outdoors. For trial organisers, automatic uploads minimise human error and reduce labour-intensive manual data collection.
Unlike with consumer wearables, Sony's partners maintain control over the mSafety user data. End-to-end data encryption is supported, so none of the customer’s application data is visible in the mSafety back-end.
Participants do not need to pair with a phone or use their WiFi connection. For simple onboarding, the mSafety watch comes with the trial App pre-loaded and connects directly with the service provider, without the need for a special subscription. Energy-efficient IoT connectivity allows for extended battery life.
Wireless data transmission reduces the need for participants to meet trial organisers. Travel time and expenses are lower, and patients are less likely to drop out before the trial is complete. Bi-directional communication supports patient compliance.
The wearable is capable of receiving data from built-in sensors and up to five external sensors via BLE. If a trial participant has not taken his or her medication at the designated time, the service provider can push out a reminder to his/her device. The patient then can respond with a single action.
The wearable is capable of receiving data from built-in sensors and up to five external sensors via BLE. If a trial participant has not taken his or her medication at the designated time, the service provider can push out a reminder to his/her device. The patient then can respond with a single action.
Benefits for pharmaceutical companies
Benefits for trial participants
In 2020, the mSafety division surveyed 2,000+ US individuals with chronic conditions
or caring for someone with one.
For example, the survey revealed how often people forget to take their medication. Emergencies could be avoided by equipping patients with connected devices capable of bi-directional communication. In clinical trials, remote monitoring devices could also support compliance.
Continuous tracking is crucial in chronic conditions. The study found ca 1/4 experienced emergencies due to missed tracking. Connected devices with bi-directional communication can prevent this.
Forgetting medications is common in chronic conditions. The study found 45% regularly forget. Remote monitoring devices hold promise in supporting compliance and reducing forgetfulness.
Find out how to optimise your clinical studies with mSafety.